NPORT-EX 2 NPORT_8690307224214278.htm iShares Evolved US Healthcare Staples ETF

Schedule of Investments  (unaudited)

April 30, 2020

   

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

    
Aerospace & Defense — 0.4%            

Lockheed Martin Corp.

     30     $ 11,672  

Northrop Grumman Corp.

     96       31,744  
   

 

 

  
      43,416  
Biotechnology — 3.4%            

Amgen Inc.

     38       9,090  

Bio-Rad Laboratories Inc., Class A(a)

    86       37,849  

Exact Sciences Corp.(a)

    665       52,522  

Guardant Health Inc.(a)

    217       16,700  

Illumina Inc.(a)

    854       272,452  

Myriad Genetics Inc.(a)(b)

    368       5,689  

NeoGenomics Inc.(a)

    480       13,123  

Veracyte Inc.(a)

    280       7,552  
   

 

 

  
      414,977  
Commercial Services — 0.6%            

Adtalem Global Education Inc.(a)

    159       5,051  

AMN Healthcare Services Inc.(a)

    264       12,403  

Bright Horizons Family Solutions Inc.(a)

    128       14,906  

Grand Canyon Education Inc.(a)

    122       10,494  

HealthEquity Inc.(a)

    87       4,895  

HMS Holdings Corp.(a)

    520       14,911  

Laureate Education Inc., Class A(a)

    272       2,576  

Strategic Education Inc.

     40       6,372  
   

 

 

  
      71,608  
Computers — 0.3%            

Leidos Holdings Inc.

     167       16,501  

MAXIMUS Inc.

     239       16,090  
   

 

 

  
      32,591  
Electrical Components & Equipment — 0.1%            

Novanta Inc.(a)

    143       12,425  
   

 

 

  
Electronics — 1.1%            

Agilent Technologies Inc.

     957       73,364  

OSI Systems Inc.(a)

    72       5,211  

PerkinElmer Inc.

     378       34,220  

Waters Corp.(a)

    145       27,115  
   

 

 

  
      139,910  
Engineering & Construction — 0.1%            

AECOM(a)

    168       6,092  
   

 

 

  
Environmental Control — 0.0%            

Stericycle Inc.(a)

    111       5,417  
   

 

 

  
Food Service — 0.1%            

Healthcare Services Group Inc.

     287       7,316  
   

 

 

  
Health Care - Products — 45.2%            

Abbott Laboratories

     9,479       872,921  

ABIOMED Inc.(a)(b)

    248       47,430  

Align Technology Inc.(a)(b)

    200       42,970  

AngioDynamics Inc.(a)

    192       2,003  

AtriCure Inc.(a)

    192       8,279  

Atrion Corp.

     8       5,055  

Avanos Medical Inc.(a)

    160       4,968  

Avantor Inc.(a)

    599       10,069  

Axogen Inc.(a)(b)

    88       858  

Baxter International Inc.

     1,504       133,525  

Bio-Techne Corp.

     112       25,200  

BioTelemetry Inc.(a)

    184       8,595  
Security   Shares     Value  
Health Care — Products (continued)            

Boston Scientific Corp.(a)

    8,839     $ 331,286  

Bruker Corp.

     304       11,953  

Cantel Medical Corp.

     104       3,848  

Cardiovascular Systems Inc.(a)

    168       7,056  

CareDx Inc.(a)(b)

    218       5,533  

Cooper Companies Inc. (The)

     264       75,689  

CryoLife Inc.(a)

    192       4,287  

Cutera Inc.(a)

    56       753  

Danaher Corp.

     2,678       437,746  

Dentsply Sirona Inc.

     671       28,477  

Edwards Lifesciences Corp.(a)

    1,341       291,667  

Glaukos Corp.(a)

    112       4,109  

Globus Medical Inc., Class A(a)

    472       22,401  

Haemonetics Corp.(a)

    192       21,846  

Henry Schein Inc.(a)

    634       34,591  

Hill-Rom Holdings Inc.

     290       32,622  

Hologic Inc.(a)

    1,241       62,174  

ICU Medical Inc.(a)

    80       17,545  

IDEXX Laboratories Inc.(a)

    328       91,053  

Inogen Inc.(a)

    104       5,200  

Inspire Medical Systems Inc.(a)

    98       7,023  

Insulet Corp.(a)(b)

    359       71,699  

Integer Holdings Corp.(a)

    120       8,935  

Integra LifeSciences Holdings Corp.(a)

    336       17,153  

Intersect ENT Inc.(a)

    88       1,010  

Intuitive Surgical Inc.(a)

    714       364,768  

iRhythm Technologies Inc.(a)

    112       11,832  

LeMaitre Vascular Inc.(b)

    88       2,507  

LivaNova PLC(a)

    289       15,352  

Luminex Corp.

     184       6,633  

Masimo Corp.(a)

    296       63,317  

Medtronic PLC

     8,263       806,717  

Merit Medical Systems Inc.(a)

    272       11,103  

Natera Inc.(a)

    345       12,779  

Natus Medical Inc.(a)

    168       4,198  

Nevro Corp.(a)

    128       15,058  

Novocure Ltd.(a)

    200       13,160  

NuVasive Inc.(a)

    288       17,533  

OraSure Technologies Inc.(a)

    312       4,973  

Orthofix Medical Inc.(a)

    95       3,368  

Patterson Companies Inc.

     322       5,886  

Penumbra Inc.(a)

    168       29,790  

Quidel Corp.(a)

    160       22,240  

ResMed Inc.

     791       122,858  

Shockwave Medical Inc.(a)

    121       4,854  

STAAR Surgical Co.(a)

    215       8,239  

Steris PLC(b)

    199       28,357  

Stryker Corp.

     2,026       377,707  

Tactile Systems Technology Inc.(a)

    106       5,472  

Tandem Diabetes Care Inc.(a)

    199       15,876  

Teleflex Inc.

     262       87,875  

Thermo Fisher Scientific Inc.

     1,517       507,710  

Varex Imaging Corp.(a)

    136       3,554  

Varian Medical Systems Inc.(a)

    368       42,092  

Wright Medical Group NV(a)

    464       13,512  

Zimmer Biomet Holdings Inc.

     1,021       122,214  
   

 

 

  
      5,509,063  
Health Care – Services — 28.1%            

Acadia Healthcare Co. Inc.(a)

    512       12,293  

Addus HomeCare Corp.(a)

    66       5,347  
 

 

 

1

Schedule of Investments  (unaudited) (continued)

April 30, 2020

   

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Health Care – Services (continued)            

Amedisys Inc.(a)

    217     $ 39,963  

Anthem Inc.

     1,237       347,263  

Brookdale Senior Living Inc.(a)

    826       2,982  

Centene Corp.(a)

    3,125       208,063  

Charles River Laboratories International Inc.(a)

    72       10,416  

Chemed Corp.

     57       23,744  

Cigna Corp.(a)

    1,462       286,230  

DaVita Inc.(a)

    552       43,614  

Encompass Health Corp.

     653       43,261  

Ensign Group Inc. (The)

     230       8,604  

HCA Healthcare Inc.

     1,674       183,939  

Humana Inc.

     773       295,147  

Invitae Corp.(a)

    393       6,504  

IQVIA Holdings Inc.(a)

    480       68,443  

Laboratory Corp. of America Holdings(a)

    510       83,870  

LHC Group Inc.(a)

    169       21,968  

Magellan Health Inc.(a)

    96       5,830  

MEDNAX Inc.(a)

    538       7,812  

Medpace Holdings Inc.(a)

    58       4,632  

Molina Healthcare Inc.(a)

    142       23,284  

National HealthCare Corp.

     64       4,376  

Quest Diagnostics Inc.

     728       80,160  

RadNet Inc.(a)

    233       3,290  

Select Medical Holdings Corp.(a)

    704       12,017  

Syneos Health Inc.(a)

    96       5,356  

Teladoc Health Inc.(a)

    256       42,135  

Tenet Healthcare Corp.(a)

    584       11,785  

Tivity Health Inc.(a)

    287       2,574  

U.S. Physical Therapy Inc.

     96       7,248  

UnitedHealth Group Inc.

     5,021       1,468,492  

Universal Health Services Inc., Class B

     449       47,455  
   

 

 

  
      3,418,097  
Household Products & Wares — 0.3%            

Church & Dwight Co. Inc.

     454       31,775  
   

 

 

  
Pharmaceuticals — 16.4%            

AbbVie Inc.

     722       59,348  

Akorn Inc.(a)(b)

    200       42  

Allergan PLC

     669       125,331  

AmerisourceBergen Corp.

     590       52,899  

Bausch Health Companies Inc.(a)(b)

    144       2,609  

Becton Dickinson and Co.

     1,544       389,906  

Cardinal Health Inc.

     1,333       65,957  

CVS Health Corp.

     5,765       354,836  

DexCom Inc.(a)

    488       163,578  

Johnson & Johnson

     3,298       494,832  

McKesson Corp.

     672       94,920  

Perrigo Co. PLC

     117       6,236  

Pfizer Inc.

     3,849       147,648  

PRA Health Sciences Inc.(a)

    112       10,808  

Premier Inc., Class A(a)

    376       12,468  
Security   Shares     Value  
Pharmaceuticals (continued)            

Zoetis Inc.

     170     $ 21,983  
   

 

 

  
      2,003,401  
Real Estate Investment Trusts — 1.3%            

Healthpeak Properties Inc.

     903       23,604  

LTC Properties Inc.

     120       4,272  

Medical Properties Trust Inc.

     1,848       31,675  

National Health Investors Inc.

     160       8,810  

Omega Healthcare Investors Inc.

     414       12,068  

Physicians Realty Trust

     656       10,116  

Sabra Health Care REIT Inc.

     640       8,205  

Ventas Inc.

     766       24,780  

Welltower Inc.

     719       36,834  
   

 

 

  
      160,364  
Retail — 0.6%            

National Vision Holdings Inc.(a)

    153       4,055  

Walgreens Boots Alliance Inc.

     1,714       74,199  
   

 

 

  
      78,254  
Software — 0.9%            

Allscripts Healthcare Solutions Inc.(a)

    726       4,719  

Cerner Corp.

     1,297       89,999  

Omnicell Inc.(a)

    159       11,591  

Tabula Rasa HealthCare Inc.(a)(b)

    80       5,067  
   

 

 

  
      111,376  
   

 

 

  

Total Common Stocks — 98.9%
(Cost: $11,147,197)

 

     12,046,082  
   

 

 

  

Short-Term Investments

 

Money Market Funds — 2.7%  

BlackRock Cash Funds: Institutional,
SL Agency Shares,
    0.89%(c)(d)(e)

    207,879       208,107  
   

BlackRock Cash Funds: Treasury,
SL Agency Shares,
    0.18%(c)(d)

    126,000       126,000  
   

 

 

  
      334,107  
   

 

 

  
Total Short-Term Investments — 2.7%
(Cost: $333,817)		         334,107  
   

 

 

  

Total Investments in Securities — 101.6%
(Cost: $11,481,014)

 

     12,380,189  
Other Assets, Less Liabilities — (1.6)%         (200,691)  
   

 

 

  
Net Assets — 100.0%         $12,179,498  
   

 

 

  

 

(a) 

Non-income producing security.

(b)

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d)

Annualized 7-day yield as of period-end.

(e)

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

 

 

2

Schedule of Investments  (unaudited) (continued)

April 30, 2020

   

iShares® Evolved U.S. Healthcare Staples ETF

 

Affiliates

Investments in issuers considered to be affiliates of the Fund during the nine months ended April 30, 2020, for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

  
Affiliated Issuer    Shares
Held at
07/31/19		      Net
Activity		      Shares
Held at
04/30/20		      Value at
04/30/20		      Income      Net Realized
Gain (Loss)(a)		     

Change in
Unrealized
Appreciation

(Depreciation)

  

 

  

BlackRock Cash Funds: Institutional,
SL Agency Shares

      249,945        (42,066 )       207,879      $ 208,107      $ 861 (b)     $ 43      $ 283  

BlackRock Cash Funds: Treasury,
SL Agency Shares

      50,000        76,000        126,000        126,000        678        —        —  
           

 

 

     

 

 

     

 

 

     

 

 

  
            $ 334,107      $ 1,539      $ 43      $ 283  
           

 

 

     

 

 

     

 

 

     

 

 

  

 

  (a) 

Includes realized capital gain distributions from an affiliated fund, if any.

 
  (b)

Includes securities lending income earned from the reinvestment of cash collateral from loaned securities (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities, and less fees paid to BTC as securities lending agent.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to a recently published shareholder report. Shareholder reports are available on the Fund’s website at iShares.com and on the U.S. Securities and Exchange Commission website at sec.gov.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of April 30, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

 

  
     Level 1        Level 2        Level 3        Total  

 

  

Investments

                  

Assets

                  

Common Stocks

    $ 12,046,082        $ —        $ —        $ 12,046,082  

Money Market Funds

      334,107          —          —          334,107  
  

 

 

       

 

 

       

 

 

       

 

 

  
   $ 12,380,189        $             —        $             —        $ 12,380,189  
  

 

 

       

 

 

       

 

 

       

 

 

  

 

 

3